Abstract The effect of ketoconazole on steroid synthesis was studied in intact (sham-operated) and castrated male and ovariectomized female rats. Rats were given 25 mg/kg ketoconazole twice a day im for 5 days. The influence of ketoconazole was also investigated on hormone release altered by GnRH, estradiol (Serono) and 17-OH-progesterone concentration (Institute of Iso¬ topes, Hungarian Academy of Sciences, Budapest). Qual¬ ity assurance methods revealed that in these kits the intraassay variation coefficients ranged between 3.63 and 5.56%; and the inter-assay variation coefficients ranged between 7.25 and 11.45%. Rat prolactin and LH were determined with rat RIA technique (NIDDK). The intraassay coefficients in these cases ranged between 3.73 and 4.92%, whereas the inter-assay variation coefficients were less than 10%.
(from 160 \ m=+-\41 to 64.6 \m=+-\12.9 \g=m\g/l ),and its priming effect on PRL release was diminished by ketoconazole (from 598 \ m=+-\ 81 to 281 \ m=+-\ 66 \g=m\g/l ). Ketoconazole 11 -hydroxylase, and mostly the 17-20-desmolase activity (1) (2) (3) (4) (5) (6) . Schurmeyer & Nieschlag (7) suggested that a phenylated side chain of the imidazole molecule is responsible for the inhibition of testosterone biosynthesis. Some data show that the substance is able to reduce ovarian aromatase ac¬ tivity in the rat (8, 9) . Basal aldosterone and cortisol levels are not necessarily altered by KZ, presumably because the inhibitory process is partial, and can be unequivocally demonstrated when the synthesis of these steroids is stimulated (10) (11) (12) (13) (NIDDK) . The intraassay coefficients in these cases ranged between 3.73 and 4.92%, whereas the inter-assay variation coefficients were less than 10%.
Brains were removed, dissected and the dopamine con¬ tent of the hypothalamus was assayed with the method of Chang (19) .
ANOVA was used to evaluate data and was followed by unpaired t-test (20 Table 2 ). The values were: 343 ± 76 and 373 ± 38 ng/1, respectively. The influence of ketoconazole (KZ), 2x25 mg/kg for 5 days, modifying the effects of GnRH, 500 ng/rat, estradiol, 25 ng/rat, and haloperidol, 0.5 mg/rat, on the serum LH and PRL levels in intact and castrated (CAST) male rats. (Table 2 ).
The action of estradiol and haloperidol on prolactin re¬ lease of ketoconazole-treated rats. Estradiol administration led to an increase in prolactin release both in placebo-and KZ-treated ovariectomized"rats. How¬ ever, this action of estradiol was significantly re¬ duced in the KZ-treated group.
Haloperidol resulted in a marked increase in prolactin levels, but this effect could not be modi¬ fied by KZ administration. The estradiol-induced prolactin release was significantly higher than that of the haloperidol-treated rats (Table 2) . Influence of ketoconazole (KZ), 2x25 mg/kg for 5 days, modifying the effects of GnRH, 500 ng/rat, estradiol (E2), 25 ng/rat, and haloperidol, 0.5 mg/rat, on the serum LH and PRL levels in ovariectomized (OVX) rats. (24) reported that KZ antagonized glucocorticoid action on the hepatoma cell receptors. Moreover, a com¬ petition between KZ and estradiol and/or dihydrotestosterone on the sex hormone binding protein has been also demonstrated (25), however, it is rather a poor inhibitor of androgen binding to sex hormone binding globulin (26, 27) . Further exper¬ iments are required for direct evidences of binding and alteration of the estrogen receptor by the drug.
Obviously, the weak but competitive binding affin¬ ity of KZ to the pituitary GnRH receptors, in vitro, may also play a role in the phenomenon (22) . The possibility also cannot be excluded that it may reduce the metabolic and renal clearance of estra¬ diol, as it has been shown for prednisolone by Zürcher et al. (28) .
